
About Us
New Drug Transformation Platform with Specialty Non-Human Primate Technologies
With decades of endeavor and aiming at filling the gap between preclinical and clinical development, PRISYS has established an integrated CRO to enhance new drug transformation, as well as a robust in vivo platform for collaboration with global drug researchers. Through combination of PRISYS’ valuable Non-human Primate (NHP) assets, forward-looking strategies, and innovative minds, we offer the biotech industry a powerful translation toolkit for the accelerated drug R&Ds.
- Clinical technologies practiced in non-clinical studies for straight translation
- Innovative NHP Models and proprietary technologies for better pharmacology
- Integration of key elements of NHP experiments for cost-effective operation
- Dedicated team of talents with industrial/clinical backgrounds for study optimization
State-of-the-Art Research Center
PRISYS Translational Research Center (PTRC) is a modern and independent building, established with one purpose: to provide a UNIQUE CARRIER for the evolving NHP technologies from PRISYS. Located in the biggest Biotech Cluster in China – Shanghai City, the PTRC has a track record of completing various R&D projects in NHP with efficiency and high quality, at industrial-scale level. The PTRC is featured by and best-known for its clinic-identical infrastructure and advanced disease-area-specialized research laboratories.
Our Promise to Deliver the Right Solutions to Your Needs
Product Categories
WHY WORKING with PRISYS
Company News
Our Promise to Deliver the Right Solutions to Your Needs